Management of anxiety disorders: a review

Shamim Akhtar; Ajeet Pal Singh; Amar Pal Singh

doi:10.37022/tjmdr.v5i2.724

Shamim Akhtar Department of Pharmacology, St. Soldier Institute of Pharmacy, Lidhran Campus, Behind NIT (R.E.C.), Jalandhar –Amritsar by pass, NH-1, Jalandhar -144011, Punjab, India.
Ajeet Pal Singh Department of Pharmacology, St. Soldier Institute of Pharmacy, Lidhran Campus, Behind NIT (R.E.C.), Jalandhar –Amritsar by pass, NH-1, Jalandhar -144011, Punjab, India.
Amar Pal Singh Department of Pharmacology, St. Soldier Institute of Pharmacy, Lidhran Campus, Behind NIT (R.E.C.), Jalandhar –Amritsar by pass, NH-1, Jalandhar -144011, Punjab, India.

DOI https://doi.org/10.37022/tjmdr.v5i2.724

Abstract

mental illnesses worldwide. There were only two medications approved by the FDA to treat anxiety from 2008 to 2024, indicating that there are limitations with current pharmacodynamic therapies, and certainly harms, delayed onset of effectiveness, and a lack innovation considering the high prevalence and impact on society. This review article also incorporates data from clinical guidelines, drug development from the pharmaceutical industry, and active research articles related to herbal therapies. This review discusses the very promising anxiolytic potential of herbs, as augmented by their low-cost and excellent safety profiles. It also discussed history of use of conventional herbal medicine and the we discussed therapeutic roles of benzodiazepines, SSRIs, SNRIs, and pipeline experimental drugs. There is much to be learned however, including the need for models of integrative therapy practices, standardized clinical trials, and an investigation of mechanisms. This review summary highlights the increased interest in practical strategies for individuals to manage anxiety, especially in applicable clinical and community health contexts where accessibility based on evidence, acceptance and safety of interventions are important factors.

Keywords: Anxiety disorders, drugs treatment, Herbal medicine, research gap, Social Applicability

References

1. Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ; WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disoders; Zohar J, Hollander E, Kasper S, Möller HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, Cassano G, Fineberg N, Gabriels L, Hindmarch I, Kaiya H, Klein DF, Lader M, Lecrubier Y, Lépine JP, Liebowitz MR, Lopez-Ibor JJ, Marazziti D, Miguel EC, Oh KS, Preter M, Rupprecht R, Sato M, Starcevic V, Stein DJ, van Ameringen M, Vega J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry. 2008;9(4):248-312. doi: 10.1080/15622970802465807. PMID: 18949648.
2. Shri R. Anxiety: causes and management. The Journal of Behavioral Science. 2010;5(1):100-18.
3. https://www.union.edu/counseling-center/resources/students/handouts/anxiety-disorders
4. Bleakley S, Davies SJ. The pharmacological management of anxiety disorders. Progress in Neurology and Psychiatry. 2014 Nov;18(6):27-32
5. Sumitkumar Sharma, Roshan Wagh, Puja Suryawanshi, Aman Upaganlawar, Manojkumar Mahajan, Chandrashekhar Upasani, Reviewing Herbal Remedies for Managing Anxiety and Depression, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 5, 1551-1565.
6. Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ, WFSBP Task Force on Mental Disorders in Primary Care, WFSBP Task Force on Anxiety Disorders, OCD and PTSD. Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care. International journal of psychiatry in clinical practice. 2012 Jun 1;16(2):77-84.
7. Bleakley S, Davies SJ. The pharmacological management of anxiety disorders. Progress in Neurology and Psychiatry. 2014 Nov;18(6):27-32.
8. Ahmad AV, Khan SW, Chaus S, Khalique QM. Review on Herbal Drugs in Treatment of Anxiety Disorder. International Journal of Advanced Research in Science, Communication and Technology 2022;2(8);337:344
9. Sonani S, Dudhamal TS. Pharmacological activity of Ayurveda herbal medicines in anxiety and depression: A review. J Drug Res Ayurvedic Sci 2023;8:113-23.
10. Tadros E, Keerthana S, Padder S, Totlani J, Hirsch D, Kaidbay DN, Contreras L, Naqvi A, Miles S, Mercado K, Meyer A. Anxiety disorders, PTSD and OCD: systematic review of approved psychiatric medications (2008–2024) and pipeline phase III medications. Drugs in Context. 2025 Apr 3;14:2024-11.

Management of anxiety disorders: a review

Abstract

References

Most read articles by the same author(s)